Azitra, Inc.
AZTR
- Revenue · TTM
- $0-100.0% YoY
- Gross profit · TTM
- $-452KFour comparable prior quarters required for growth
- Operating income · TTM
- $-11.8MFour comparable prior quarters required for growth
- Free cash flow · TTM
- $-2.5BFour comparable prior quarters required for growth
About Azitra, Inc.
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease. It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
Operating metrics
The measures behind the business.
No operating metrics are currently published for this company.
Revenue mix
What the company sells, and where.
No revenue breakdown is currently published for this company.
Income statement
From revenue to profit.
Cash flow
Cash generated and cash spent.
Balance sheet
What the company owns and what it owes.
Financial statements
Every published field, with exact amounts and disclosure sources.
View full financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 7,492,500USD | 0USD | 7,500USD |
| Cost Of Revenue | 116,653USD | 113,104USD | 112,000USD | 110,622USD | 117,415USD | 115,748USD | 103,633USD | 113,940USD |
| Gross Profit | -116,653USD | -113,104USD | -112,000USD | -110,622USD | -117,415USD | -115,748USD | -103,633USD | 7,500USD |
| Research Development | 1,560,565USD | 4,832,175,983USD | 1,180,078USD | 1,401,839USD | 1,250,100USD | 1,116,049USD | 1,015,807USD | 1,118,552USD |
| Selling General Administrative | 2,373,359,000USD | 6,125,748,943USD | 1,588,406USD | 1,469,513,000USD | 1,850,138USD | 6,264,310,845USD | 1,913,400USD | 1,549,228USD |
| Unclassified Operating Expenses | -2,371,102,294USD | -10,955,811,439USD | — | -1,468,154,109USD | — | -6,263,108,486USD | — | — |
| Total Operating Expenses | 3,817,271USD | 2,113,487USD | 2,768,484USD | 2,760,730USD | 3,100,238USD | 2,318,408USD | 2,929,207USD | 2,667,780USD |
| Operating Income | -3,933,924USD | -2,226,591USD | -2,768,484USD | -2,871,352USD | -3,100,238USD | -2,434,156USD | -2,929,207USD | -2,660,280USD |
| Interest Income | 14,719USD | 12,761USD | 4,823USD | 15,461USD | 37,164USD | 121,369USD | 47,389USD | 16,268USD |
| Interest Expense | 3,411USD | 366,174USD | 372USD | 468USD | 1,293USD | 5,612USD | 3,851USD | 1,782USD |
| Net Interest Income | 11,308USD | 7,307USD | 4,451USD | 14,993USD | 35,871USD | 275,938USD | 43,538USD | 14,486USD |
| Income Before Tax | -3,927,240USD | -2,225,185USD | -2,764,528USD | -2,888,993USD | -3,068,345USD | -2,384,102USD | -1,009,491USD | -2,631,993USD |
| Tax Provision | 0USD | 8,319USD | 0USD | 0USD | 0USD | -684USD | 0USD | 0USD |
| Net Income | -3,927,240USD | -2,233,504USD | -2,764,528USD | -2,888,993USD | -3,068,345USD | -2,393,133USD | -1,009,491USD | -2,631,993USD |
| Net Income From Continuing Ops | -3,927,240USD | -2,233,504USD | -2,764,528USD | -2,888,993USD | -3,068,345USD | -137,496USD | -1,009,491USD | -2,631,993USD |
| Ebit | -3,933,924USD | -1,859,011USD | -2,764,156USD | -2,888,527USD | -3,067,052USD | -2,378,493USD | -1,005,640USD | -2,630,211USD |
| Ebitda | -3,817,271USD | -1,745,907USD | -2,652,155USD | -2,777,905USD | -2,949,637USD | -2,262,745USD | -902,006USD | -2,516,271USD |
| Depreciation And Amortization | 116,653USD | 113,104USD | 112,001USD | 110,622USD | 117,415USD | 115,748USD | 103,634USD | 113,940USD |
| Reconciled Depreciation | 116,653USD | 113,104USD | 112,001USD | 110,624USD | 117,415USD | 115,748USD | 103,634USD | 114,854USD |
| Total Other Income Expense Net | 6,684USD | 1,406USD | 3,956USD | -17,641USD | 31,893USD | 50,054USD | 1,919,716USD | 28,287USD |
| Income Tax Expense | — | 8,319USD | — | — | — | 9,031USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 113,940USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 7,500,000USD | 686,000USD | 284,000USD | 110,000USD | — |
| Cost Of Revenue | 453,144USD | 448,235USD | 425,549USD | 405,977USD | 84,772USD | — |
| Gross Profit | -453,144USD | 7,500,000USD | 686,000USD | 284,000USD | 110,000USD | — |
| Research Development | 4,836,008,000USD | 4,723,378,000USD | 3,643,214USD | 6,097,938USD | 5,380,102USD | — |
| Selling General Administrative | 6,130,657,000USD | 6,269,262,000USD | 4,493,332USD | 3,639,666USD | 3,951,352USD | — |
| Unclassified Operating Expenses | -10,956,151,479USD | — | — | — | — | — |
| Total Operating Expenses | 10,513,521USD | 10,992,640,000USD | 8,136,546USD | 9,737,604USD | 9,331,454USD | — |
| Operating Income | -10,966,665USD | -10,985,140,000USD | -7,450,546USD | -9,453,604USD | -9,221,454USD | — |
| Interest Income | 70,209USD | 122,553USD | 1,577USD | 4,818USD | 8,759USD | — |
| Interest Expense | 7,587USD | 12,160USD | 167,726USD | 251,891USD | 66,968USD | — |
| Net Interest Income | 62,622USD | 110,393USD | -349,893USD | -247,073USD | -58,209USD | — |
| Income Before Tax | -10,947,051USD | -8,958,461USD | -11,266,473USD | -10,680,366USD | -8,939,675USD | — |
| Income Tax Expense | 8,319USD | 9,031USD | 17,308USD | -727,798USD | 174,450USD | — |
| Tax Provision | 8,319USD | 9,031USD | 17,308USD | 0USD | 0USD | — |
| Net Income | -10,955,370USD | -8,967,492USD | -11,283,781USD | -10,680,366USD | -8,939,675USD | — |
| Net Income From Continuing Ops | -10,955,370USD | -8,967,492USD | -11,283,781USD | -10,680,366USD | -8,939,675USD | — |
| Ebit | -10,939,464USD | -8,946,301USD | -11,098,747USD | -10,428,475USD | -8,872,707USD | -6,890,847USD |
| Ebitda | -10,486,320USD | -8,498,066USD | -10,673,198USD | -10,022,498USD | -8,787,935USD | — |
| Depreciation And Amortization | 453,144USD | 448,235USD | 425,549USD | 405,977USD | 84,772USD | — |
| Reconciled Depreciation | 453,144USD | 448,235USD | 417,040USD | 405,977USD | 84,772USD | — |
| Total Other Income Expense Net | 19,614USD | 10,976,181,539USD | -3,815,927USD | -1,226,762USD | 281,779USD | — |
| Net Income Applicable To Common Shares | — | — | — | -13,449,350USD | -11,708,659USD | -6,811,147USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,916,046USD | 12,126,804USD | 5,025,386USD | 4,300,279USD | 3,956,022USD | 5,907,891USD | 7,358,802USD | 9,777,499USD |
| Cash And Equivalents | 6,727,810USD | — | — | — | — | — | — | — |
| Total Current Assets | 7,443,822USD | 10,760,141USD | 3,019,327USD | 2,230,045USD | 1,799,690USD | 3,871,554USD | 5,228,290USD | 7,634,830USD |
| Other Non Current Assets | 47,042USD | — | — | — | — | — | — | — |
| Total Liabilities | 1,581,707USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,530,709USD | 1,549,781USD | 1,067,966USD | 1,806,103USD | 1,452,361USD | 1,280,421USD | 1,375,857USD | 1,367,967USD |
| Other Current Liabilities | 673,669USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 7,334,339USD | 10,480,283USD | 3,801,230USD | 2,279,176USD | 2,228,971USD | 4,407,624USD | 5,698,298USD | 8,058,253USD |
| Total Equity Including Noncontrolling Interest | 7,334,339USD | — | — | — | — | — | — | — |
| Net Receivables | 909USD | 5,108,000USD | 141,295USD | 10,366USD | 78,407USD | 103,046USD | 101,896USD | 9,923USD |
| Property Plant Equipment Net | 942,877USD | 864,962USD | 962,076USD | 1,071,409USD | 1,170,318USD | 1,089,567USD | 1,205,872USD | 1,272,532USD |
| Intangible Assets | 330,039USD | 334,522USD | 316,673USD | 270,992USD | 258,665USD | 244,140USD | 246,420USD | 248,739USD |
| Accounts Payable | 497,985USD | 932,217USD | 399,356USD | 718,476USD | 635,842USD | 558,924USD | 490,255USD | 588,460USD |
| Short Term Debt | 357,569USD | 246,590USD | 265,887USD | 580,298USD | 303,353USD | 254,103USD | 271,243USD | 292,526USD |
| Common Stock | 6,060USD | 1,619USD | 1,074USD | 561USD | 1,798USD | 1,498USD | 763USD | 763USD |
| Retained Earnings | -75,796,096USD | -72,448,436USD | -68,521,196USD | -66,287,692USD | -63,523,164USD | -60,634,170USD | -57,565,825USD | -55,172,692USD |
| Other Current Assets | — | 704,030,000USD | 809,949USD | 817,801USD | 675,553USD | 561,798USD | 571,675USD | 364,673USD |
| Total Liab | — | 1,646,521USD | 1,224,156USD | 2,021,103USD | 1,727,051USD | 1,500,267USD | 1,660,504USD | 1,719,246USD |
| Other Current Liab | — | 370,974USD | 402,723USD | 507,329USD | 513,166USD | 467,394USD | 602,787USD | 486,981USD |
| Capital Stock | — | 1,619USD | 1,074USD | 561USD | 1,798USD | 1,498USD | 763USD | 763USD |
| Cash | — | 10,051,003USD | 2,068,083USD | 1,401,878USD | 1,045,730USD | 3,206,710USD | 4,554,719USD | 7,260,234USD |
| Cash And Short Term Investments | — | 10,051,003USD | 2,068,083USD | 1,401,878USD | 1,045,730USD | 3,206,710USD | 4,554,719USD | 7,260,234USD |
| Net Debt | — | -9,707,673USD | -1,646,006USD | -606,631USD | -467,871USD | -2,732,999USD | -3,999,210USD | -6,616,886USD |
| Short Long Term Debt Total | — | 343,330USD | 422,077USD | 795,247USD | 577,859USD | 473,711USD | 555,509USD | 643,348USD |
| Property Plant Equipment Gross | — | 1,531,088USD | 1,595,121USD | 1,673,215USD | 1,745,222USD | 1,633,363USD | 1,720,875USD | 1,757,386USD |
| Common Stock Shares Outstanding | — | 15,517,992shares | 4,873,552shares | 4,117,753shares | 2,444,380shares | 1,977,705shares | 1,145,646shares | 873,026shares |
| Non Current Assets Total | — | 1,366,663USD | 2,006,059USD | 2,070,233USD | 2,156,332USD | 2,036,337USD | 2,130,512USD | 2,142,669USD |
| Non Current Liabilities Total | — | 96,740,000USD | 156,190USD | 215,000USD | 274,690USD | 219,846USD | 284,647USD | 351,279USD |
| Non Currrent Assets Other | — | 167,179,000USD | 727,310USD | 727,832USD | 727,349USD | 702,630USD | 678,220USD | 621,398USD |
| Net Working Capital | — | 9,210,360USD | 1,951,361USD | 423,942USD | 347,329USD | 2,591,133USD | 3,852,433USD | 6,266,863USD |
| Unclassified Current Assets | — | -708,428,862USD | — | — | — | — | — | — |
| Unclassified Non Current Assets | — | -167,011,821USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 96,740,000USD | — | — | — | — | — | — |
| Unclassified Equity | — | 82,925,481USD | 72,320,278USD | 68,565,746USD | 65,748,539USD | 65,038,798USD | 63,262,597USD | 63,229,419USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 5,025,386USD | 7,358,802USD | 5,115,486USD | 7,167,443USD | 10,201,333USD | — |
| Intangible Assets | 316,673USD | 246,420USD | 210,881USD | 219,567USD | 97,693USD | — |
| Other Current Assets | 951,102,705USD | 571,675USD | 516,116USD | 377,019USD | 110,289USD | — |
| Total Liab | 1,224,156USD | 1,660,504USD | 2,202,340USD | 43,427,753USD | 35,967,252USD | — |
| Total Stockholder Equity | 3,801,230USD | 5,698,298USD | 2,913,146USD | -36,260,310USD | -25,765,919USD | — |
| Other Current Liab | 795,423,644USD | 602,787USD | 383,668USD | 993,961USD | 475,485USD | 10,133USD |
| Common Stock | 1,074USD | 763USD | 1,210USD | 104USD | 104USD | 1,444USD |
| Capital Stock | 1,074USD | 763USD | 1,210USD | 1,470USD | 1,469USD | — |
| Retained Earnings | -68,521,196USD | -57,565,825USD | -48,598,333USD | -37,314,552USD | -26,634,186USD | -17,694,511USD |
| Cash | 2,068,083USD | 4,554,719USD | 1,795,989USD | 3,492,656USD | 8,044,262USD | — |
| Cash And Short Term Investments | 2,068,083USD | 4,554,719USD | 1,795,989USD | 3,492,656USD | 8,044,262USD | — |
| Total Current Assets | 3,019,327USD | 5,228,290USD | 2,535,579USD | 4,135,883USD | 8,488,729USD | 16,573,625USD |
| Total Current Liabilities | 1,067,966USD | 1,375,857USD | 1,603,195USD | 2,222,032USD | 1,209,587USD | 1,002,539USD |
| Net Debt | -1,646,006USD | -3,999,210USD | -910,042USD | 4,235,624USD | -7,052,243USD | — |
| Short Term Debt | 265,887,000USD | 271,243USD | 322,255USD | 287,384USD | — | — |
| Short Long Term Debt Total | 422,077USD | 555,509USD | 885,947USD | 7,728,280USD | 992,019USD | — |
| Net Receivables | 141,295USD | 101,896USD | 223,474USD | 266,208USD | 334,178USD | 528,350USD |
| Accounts Payable | 399,356USD | 490,255USD | 897,272USD | 784,687USD | 717,800USD | 417,370USD |
| Property Plant Equipment Net | 962,076USD | 1,205,872USD | 1,579,037USD | 1,963,655USD | 946,681USD | 582,411USD |
| Property Plant Equipment Gross | 1,595,121USD | 1,720,875USD | 1,981,024USD | 2,250,204USD | 1,115,665USD | — |
| Common Stock Shares Outstanding | 4,873,552shares | 567,568shares | 34,514shares | 60,493shares | 60,493shares | — |
| Non Current Assets Total | 2,006,059USD | 2,130,512USD | 2,579,907USD | 3,031,560USD | 1,712,604USD | — |
| Non Current Liabilities Total | 156,190USD | 284,647USD | 599,145USD | 41,205,721USD | 34,757,665USD | — |
| Non Currrent Assets Other | 727,310USD | 678,220USD | 789,989USD | 848,338USD | 668,230USD | — |
| Net Working Capital | 1,951,361USD | 3,852,433USD | 932,384USD | 1,913,851USD | 7,279,142USD | — |
| Unclassified Current Assets | -950,292,756USD | 4,554,719USD | — | — | — | 16,045,275USD |
| Unclassified Current Liabilities | -1,060,642,034USD | — | — | — | — | — |
| Unclassified Equity | 72,320,278USD | 63,262,597USD | 56,624,545USD | 1,052,668USD | — | — |
| Good Will | — | 246,173,580USD | — | — | — | — |
| Other Assets | — | 4,106USD | — | 848,338USD | 668,230USD | 520,688USD |
| Short Term Investments | — | -4,550,164,281USD | — | — | — | — |
| Unclassified Non Current Assets | — | -246,177,686USD | — | — | — | — |
| Current Deferred Revenue | — | — | -322,255USD | 156,000USD | 15,000USD | — |
| Inventory | — | — | -215,219USD | 216,886USD | — | — |
| Accumulated Other Comprehensive Income | — | — | -5,115,486USD | — | — | — |
| Deferred Long Term Liab | — | — | — | 800,831USD | 620,029USD | 473,406USD |
| Other Liab | — | — | — | 70,283USD | 71,104USD | 72,093USD |
| Long Term Debt | — | — | — | 6,600,000USD | 992,019USD | — |
| Net Tangible Assets | — | — | — | -36,479,877USD | -25,863,612USD | -17,181,857USD |
| Unclassified Non Current Liabilities | — | — | — | 33,734,607USD | 33,074,513USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,927,240,000USD | -2,233,504USD | -2,764,528USD | -2,888,993USD | -3,068,345USD | -2,393,133USD | -1,009,491USD | -2,631,993USD |
| Depreciation | 116,653,000USD | 113,104USD | 112,000USD | 110,624USD | 117,415USD | 115,748USD | 103,634USD | 113,940USD |
| Stock Based Compensation | 6,149,000USD | 12,146USD | 4,165USD | 16,031USD | 30,402USD | 33,178USD | 143,534USD | 34,170USD |
| Other Non Cash Items | 1,326,432,561USD | 2,281USD | 8,115USD | 7,672USD | -1,318USD | -75USD | -1,426,691USD | -16,654USD |
| Change To Account Receivables | -19,453USD | -113,715USD | 62,399USD | 13,067USD | -1,150USD | -80,401USD | 101,972USD | 22,314USD |
| Change In Working Capital | 701,439USD | -786,638USD | 199,697USD | -60,370USD | -149,916USD | -341,919USD | -286,570USD | 398,590USD |
| Total Cash From Operating Activities | -2,477,304,000USD | -2,892,611USD | -2,444,716USD | -2,815,036USD | -3,071,762USD | -2,586,201USD | -2,475,584USD | -2,101,947USD |
| Capital Expenditures | -14,928,000USD | -83,858USD | -3,364USD | -36,287USD | -24,839USD | -115,532USD | -107,888USD | -74,748USD |
| Free Cash Flow | -2,492,232,000USD | -2,976,469USD | -2,448,080USD | -2,851,323USD | -3,096,601USD | -2,701,733USD | -2,583,472USD | -2,176,695USD |
| Total Cashflows From Investing Activities | -37,139,000USD | -83,858USD | -41,078USD | -36,287USD | -21,686USD | -115,532USD | -107,888USD | -74,748USD |
| Net Borrowings | -4,261USD | -4,161USD | -4,062USD | -3,966USD | -3,872USD | -3,782USD | -3,693USD | — |
| Total Cash From Financing Activities | 10,497,363,000USD | 3,642,674USD | 2,841,942USD | 690,343USD | 1,745,439USD | -3,782USD | 9,040,624USD | -21,381USD |
| Issuance Of Capital Stock | 10,600,144USD | 3,743,698USD | 2,846,004USD | 694,309USD | 1,749,311USD | 0USD | 9,064,244USD | -227USD |
| Change In Cash | 7,982,920,000USD | 666,205USD | 356,148USD | -2,160,980USD | -1,348,009USD | -2,705,515USD | 6,457,152USD | -2,198,076USD |
| Begin Period Cash Flow | 2,068,083,000USD | 1,401,878USD | 1,045,730USD | 3,206,710USD | 4,554,719USD | 7,260,234USD | 803,082USD | 3,001,158USD |
| End Period Cash Flow | 10,051,003,000USD | 2,068,083USD | 1,401,878USD | 1,045,730USD | 3,206,710USD | 4,554,719USD | 7,260,234USD | 803,082USD |
| Other Cashflows From Investing Activities | -22,211,000USD | -74,609USD | — | -24,686,000USD | 3,153USD | — | -99,319USD | — |
| Other Cashflows From Financing Activities | 10,486,865,637USD | -96,863USD | — | 690,343,000USD | 1,743,693,561USD | 13,354,691USD | -19,927USD | -17,550USD |
| Investments | — | — | -41,078USD | -36,287USD | -21,686USD | -115,532USD | -107,888USD | -74,748USD |
| Unclassified Investing Cash Flow | — | — | — | 24,722,287USD | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | -690,343,000USD | -1,743,693,561USD | -13,354,691USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -10,955,370USD | -8,967,492USD | -11,283,781USD | -10,680,366USD | -8,939,675USD | -6,811,147USD |
| Depreciation | 453,144USD | 448,235USD | 425,549USD | 405,977USD | 84,772USD | 57,034USD |
| Stock Based Compensation | 62,744USD | 245,053USD | 151,505USD | 184,465USD | 306,055USD | — |
| Other Non Cash Items | 12,584USD | -1,467,818USD | 4,097,781USD | 1,429,694USD | -164,861USD | — |
| Change To Account Receivables | -39,399USD | 133,150USD | 42,734USD | 66,668USD | 194,172USD | 194,417USD |
| Change In Working Capital | -797,227USD | -441,718USD | -753,429USD | 310,761USD | 646,350USD | -113,112USD |
| Total Cash From Operating Activities | -11,224,125USD | -10,183,740USD | -7,362,375USD | -8,349,469USD | -8,067,359USD | -6,540,698USD |
| Capital Expenditures | -186,062USD | -379,246USD | -318,259USD | -341,011USD | -652,275USD | -217,687USD |
| Free Cash Flow | -11,410,187USD | -10,562,986USD | -7,680,634USD | -8,690,480USD | -8,719,634USD | — |
| Total Cashflows From Investing Activities | -182,909USD | -379,246USD | -318,259USD | -336,761USD | -652,275USD | -541,036USD |
| Net Borrowings | -16,061USD | -14,598USD | -7,392USD | 4,350,000USD | 984,387USD | 230,685USD |
| Total Cash From Financing Activities | 8,920,398USD | 13,321,716USD | 5,983,967USD | 4,134,624USD | 992,862USD | 16,551,750USD |
| Issuance Of Capital Stock | 9,033,322USD | 13,354,691USD | 5,991,359USD | 0USD | — | — |
| Change In Cash | -2,486,636USD | 2,758,730USD | -1,696,667USD | -4,551,606USD | -7,726,772USD | 9,470,016USD |
| Begin Period Cash Flow | 4,554,719USD | 1,795,989USD | 3,492,656USD | 8,044,262USD | 15,771,034USD | — |
| End Period Cash Flow | 2,068,083USD | 4,554,719USD | 1,795,989USD | 3,492,656USD | 8,044,262USD | 15,771,034USD |
| Other Cashflows From Investing Activities | -158,696USD | -370,677USD | -291,715USD | -303,660USD | -206,139USD | -316,779USD |
| Other Cashflows From Financing Activities | -96,863USD | -18,377USD | -318,259USD | -215,376USD | 8,475USD | -216,886USD |
| Investments | — | -379,246USD | -318,259USD | -336,761USD | -652,275USD | — |
| Change To Inventory | — | — | -613,310USD | -229,038USD | 385,947USD | — |
| Change To Liabilities | — | — | — | 665,397USD | 529,721USD | -307,529USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 16,537,951USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. TTM requires four complete quarters. Missing values are not zero. Charts use rounded labels; expand values and sources for exact amounts. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.